Balter Liquid Alternatives’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$904K Sell
40,988
-15,681
-28% -$364K 0.44% 81
2019
Q1
$1.34M Buy
56,669
+15,230
+37% +$356K 0.74% 47
2018
Q4
$922K Buy
41,439
+8,872
+27% +$213K 0.64% 55
2018
Q3
$848K Buy
32,567
+9,855
+43% +$273K 0.69% 50
2018
Q2
$628K Buy
22,712
+2,943
+15% +$78K 0.49% 68
2018
Q1
$512K Buy
19,769
+9,808
+98% +$268K 0.49% 68
2017
Q4
$274K Sell
9,961
-25,089
-72% -$665K 0.27% 108
2017
Q3
$553K Buy
+35,050
New +$793K 0.62% 38

Other funds holding TBI

Balter Liquid Alternatives's TBI Position: Q2 2019 in Review

Balter Liquid Alternatives reduced its Trueblue (TBI) stake by 28% in Q2 2019, selling an estimated $364K and leaving 40,988 shares worth $904K. The position accounts for 0.44% of the portfolio, ranked #81.

Balter Liquid Alternatives first reported a position in TBI in Q3 2017 and has held it in 8 quarters since. The position peaked at $1.34M in Q1 2019. 185 funds tracked by Wall St. Rank hold TBI as of Q2 2019.

  • Balter Liquid Alternatives held 40,988 shares of Trueblue worth $904K as of Q2 2019.
  • Balter Liquid Alternatives sold 15,681 Trueblue shares in Q2 2019, an estimated $364K.
  • Trueblue made up 0.44% of Balter Liquid Alternatives's portfolio in Q2 2019, its #81 holding.
  • Balter Liquid Alternatives first reported a position in Trueblue in Q3 2017 and has held it in 8 quarters since.
  • Balter Liquid Alternatives's Trueblue position peaked at $1.34M in Q1 2019.
  • 185 funds tracked by Wall St. Rank held Trueblue as of Q2 2019.

Based on Balter Liquid Alternatives's 13F filing for Q2 2019, filed 31 Jul 2019.